|
|
|
|
|
Article Related to Pharmacy Cleanroom Project Management Considerations: An Experience-Based Perspective |
Title (Click for Abstract / Details) |
Author |
Issue |
Page |
View/Buy |
Pharmacy Cleanroom Project Management Considerations: An Experience-Based Perspective |
Kastango Eric S, DeMarco Sam
|
May/Jun 2001 |
221-225 |
View Sample |
Tips for Cleanroom Construction and Renovation |
Mixon William, Huffman Lanny
|
Mar/Apr 2009 |
100-104 |
Buy |
Cleanroom Cleanliness |
Mulder Kyle
|
Jan/Feb 2021 |
6-12 |
Buy |
Basics of Sterile Compounding: Contamination Control |
Akers Michael J
|
May/Jun 2015 |
232-238 |
Buy |
PostScription: Cleanroom Standards |
Fitzpatrick Mike, Goldstein Ken
|
Mar/Apr 2004 |
160 |
Buy |
Maintenance of the Cleanroom |
Allen Loyd V Jr
|
Jul/Aug 2001 |
313 |
Buy |
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom |
Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
|
Jul/Aug 2015 |
268-278 |
Buy |
Depyrogenation Options for the Compounding Cleanroom |
Weller Tom, Bell Jeff, Dullinger Roger, Allen Vern, Anthenat Bruce
|
Nov/Dec 2014 |
446-454 |
Buy |
Examination of the Order of Incubation for the Recovery of Bacteria and Fungi from Pharmaceutical-grade Cleanrooms |
Sandle Tim
|
May/Jun 2014 |
242-247 |
Buy |
Cleaning of Isolators: A Vital Part of a Contamination Control Program |
Rossington Karen
|
Nov/Dec 2004 |
452-456 |
Buy |
A Dialogue Concerning Contamination Control Systems: Where Does the Isolator Fit In? |
Vandenbroucke Johan, Rahe Hank
|
Jan/Feb 2005 |
33-35 |
Buy |
Cross-contamination in Porcelain Mortars |
Bauer-Brandl Annette, Falck Astrid, Ingebrigtsen Lars, Nilsen Cathrina
|
Nov/Dec 2001 |
476-479 |
Buy |
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination |
Allen Loyd V Jr
|
Nov/Dec 2006 |
446-448 |
Buy |
Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags |
Breukels Oscar, van der Gronde Toon, Simons-Sanders Kathleen, Crul Mirjam
|
Jul/Aug 2018 |
345-349 |
Buy |
Contamination Control in Compounding Areas |
Mulder Kyle, Gonzales Ben A
|
Jul/Aug 2019 |
271-278 |
Buy |
Is Your Cleanroom Clean? An In-depth Look at Cleaning and Disinfecting Agents, Procedures, and Requirements for the Compounding Pharmacist |
Jeffrey Megan
|
Mar/Apr 2006 |
113-119 |
Buy |
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use |
Allen Loyd V Jr, Okeke Claudia C
|
May/Jun 2008 |
252-257 |
Buy |
Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings |
Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
|
Mar/Apr 2013 |
168-174 |
Buy |
Study of Microbiological Safety of 25 Oncology Drugs After Multiple Uses in Aseptic Conditions |
Roy Julie, Brault Julie, Joran Pierre, Metrop Raphael, Hildgen Patrice
|
Sep/Oct 2011 |
428-434 |
Buy |
Efficacy of an Automated Robotic Cleaning Device for Compounding Pharmacies |
Polonini Hudson, Dijkers Eli CF, Ferreira Anderson O, da Silva Sharlene L, Araújo Paulo Victor C, Koulouridas Savvas
|
Sep/Oct 2020 |
426-433 |
Buy |
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs |
Dillon L R
|
Jan/Feb 2020 |
30-36 |
Buy |
Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2
|
Martin Matt
|
Nov/Dec 2018 |
475-478 |
Buy |
Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding |
Akers Michael J
|
Jul/Aug 2016 |
307-314 |
Buy |
Basics of Sterile Compounding: Aseptic Processing |
Akers Michael J
|
Jan/Feb 2015 |
49-56 |
Buy |
Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards |
Kastango Eric S
|
May/Jun 2008 |
216-229 |
Buy |
Microbial Air-Sampling Equipment, Part 2: Experiences of Compounding Pharmacists |
Mixon Bill, Cabaleiro Joe, Latta Kenneth S, Vail Jane
|
Jul/Aug 2008 |
321-327 |
Buy |
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control |
Allen Loyd V Jr, Okeke Claudia C
|
May/Jun 2009 |
234-238 |
Buy |
Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients |
Mixon Bill, Ille Gary
|
Jul/Aug 2009 |
290-294 |
Buy |
Waterless Alcohol-based Hand Sanitizers for the Compounding Pharmacy |
Mixon William, Wood Adam P, Low Jennifer, Homan Linda
|
Jul/Aug 2011 |
278-284 |
Buy |
PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone |
Cabaleiro Joe
|
Jan/Feb 2012 |
86-87 |
Buy |
Evaluation of Containment Ventilated Enclosure Performance in Absence of Negative Pressure Containment Secondary Engineering Control |
Hutson Chad, Day A J
|
Nov/Dec 2019 |
511-518 |
Buy |
How to Qualify Container Closure Systems for Intended Use, Part 1 |
Kim Amy A, Gehrmann Matthew R, McCaw James, McAndrew T Page
|
Nov/Dec 2019 |
454-461 |
Buy |
Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators |
Mulder Kyle
|
Nov/Dec 2019 |
447-452 |
Buy |
Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding |
Allen Loyd V Jr
|
Nov/Dec 2019 |
478-482 |
Buy |
Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities |
Weller Tom, Kragseth Rolf, Dullinger Roger, Illum Henrik, Perry Alan
|
May/Jun 2015 |
182-192 |
Buy |
Questions and Answers: USP Chapter <797> and JCAHO Compliance |
Allen Loyd V Jr
|
Jan/Feb 2005 |
29-31 |
Buy |
Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance |
Grilli Anthony, Sutton Scott
|
Jan/Feb 2015 |
30-37 |
Buy |
Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study |
Peters Gregory F, McKeon Marghi R, Nerbun Richard G
|
Nov/Dec 2007 |
450-470 |
Buy |
PostScription: Experts Everywhere |
Rahe Hank
|
Mar/Apr 2005 |
167 |
Buy |
Pharmacy Compounding Urban Legends |
Kastango Eric S
|
Jan/Feb 2006 |
32-34 |
Buy |
Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists |
Rahe Hank
|
Mar/Apr 2004 |
89-94 |
Buy |
Improving the Management, Operations and Cost Effectiveness of Sterile-Product Compounding |
Kastango Eric S, Douglass Kate
|
Jul/Aug 1999 |
253-258 |
Buy |
Particulates in Parenterals |
Allen Loyd V Jr
|
Jan/Feb 2000 |
43 |
Buy |
Analysis of Extemporaneous Alprostadil Formulations |
Sarver Jeffrey G, Peng Ning, Lerdkanchanaporn Supaporn, Oravecz-Wilson Katherine, Alexander Kenneth S, Erhardt Paul W
|
Mar/Apr 1999 |
148-155 |
Buy |
Quality-Control Analytical Methods: USP Chapter <797> Compounded Sterile Preparations Sterility Requirements and Their Relationship to Beyond-Use Dating |
Kastango Eric S
|
Sep/Oct 2004 |
393-397 |
Buy |
Basics of Compounding: Application of the United States Pharmacopeia Bacterial Endotoxins Test to Compounded Sterile Preparations |
Dawson Michael F
|
Jan/Feb 2006 |
36-39 |
Buy |
Aseptic Compounding in New Zealand and the Use of Still Air Boxes |
Gargiulo Derryn, Kairuz Therese Eileen
|
Jul/Aug 2006 |
293-295 |
Buy |
Standard Operating Procedure: Testing of Water Supply: Barnstead D4751 High Purity Water System |
Allen Loyd V Jr
|
Jul/Aug 2006 |
296-297 |
Buy |
Putting the Science Back into the "Art and Science" of Compounding |
Kastango Eric S
|
Jul/Aug 2006 |
263-268 |
Buy |
PostScription: Challenges Facing an Analytical Laboratory |
Kupiec Thomas C
|
Nov/Dec 2006 |
479-480 |
Buy |
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 4: Considerations in Selection and Use of Disinfectants and Antiseptics |
Allen Loyd V Jr, Okeke Claudia C
|
Nov/Dec 2007 |
492-499 |
Buy |
Calculations: High-Technology Compounding and Investigational Dispensing |
Webb Sheldon D, Stockton Shelly J
|
Nov/Dec 2007 |
500-501 |
Buy |
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations |
Allen Loyd V Jr, Okeke Claudia C
|
Jan/Feb 2008 |
54-60 |
Buy |
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797> |
Allen Loyd V Jr, Okeke Claudia C
|
Mar/Apr 2008 |
136-144 |
Buy |
Basics of Compounding for the Implementation of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 1 |
Allen Loyd V Jr, Okeke Claudia C
|
May/Jun 2007 |
230-236 |
Buy |
Quality-Control Analytical Methods: A Discussion of United States Pharmacopeia Chapter <71> Sterility Tests |
Kupiec Thomas C
|
Sep/Oct 2007 |
400-403 |
Buy |
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels |
Allen Loyd V Jr, Okeke Claudia C
|
Sep/Oct 2007 |
404-410 |
Buy |
Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion |
Desai Narendra R, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A
|
Sep/Oct 2007 |
426-432 |
Buy |
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued) |
Okeke Claudia C, Allen Loyd V Jr
|
Jul/Aug 2009 |
322-329 |
Buy |
Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting |
McElhiney Linda F
|
Jul/Aug 2009 |
300-310 |
Buy |
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chater <797> Pharmaceutical Compounding--Sterile Preparations, Part 15: Personnel Training, Cleansing, and Garbing |
Okeke Claudia C, Allen Loyd V Jr
|
Sep/Oct 2009 |
420-426 |
Buy |
Quality Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 1 |
Dubczak John, Latta Kenneth S, Hedman Hilary, Smith Donald R
|
Sep/Oct 2010 |
407-414 |
Buy |
Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 1 |
Latta Kenneth S, Cabaleiro Joe, Whitehead Paul, Edison Doug
|
Mar/Apr 2011 |
133-144 |
Buy |
Misinterpretation of United States Pharmacopeia Chapter <797> |
McElhiney Linda F
|
Jan/Feb 2012 |
6-10 |
Buy |
I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease |
McElhiney Linda F
|
May/Jun 2012 |
190-195 |
Buy |
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 3: Testing |
Allen Loyd V Jr
|
Jul/Aug 2012 |
322-328 |
Buy |
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 4: Cleaning and Packaging |
Allen Loyd V Jr
|
Sep/Oct 2012 |
405-414 |
Buy |
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis |
Lyon Joanna
|
Nov/Dec 2012 |
456-460 |
Buy |
Sterilization of Compounded Parenteral Products: Verification of Autoclaves |
Rahe Hank
|
Mar/Apr 2013 |
94-98 |
Buy |
Quality Control Analytical Methods: Strategies to Ensure a Robust Quality-control Microbiology Program |
Griffiths Tricia, Connors Anne
|
Mar/Apr 2013 |
130-134 |
Buy |
PreScription: American Pharmacists Month: A Time for Taking Responsibility |
Menighan Thomas E
|
Sep/Oct 2011 |
356 |
Buy |
Using ACDs in the Practice of Pharmacy |
Kastango Eric S
|
Jan/Feb 2005 |
15-21 |
Buy |
Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations |
Trissel Lawrence A
|
Nov/Dec 2008 |
524-528 |
Buy |
Basics of Compounding: United States Pharmacopeia General Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 10: First Revision: The Main Changes, Events, and Rationale |
Okeke Claudia C, Newton David W, Kastango Eric S, Allen Loyd V Jr
|
Nov/Dec 2008 |
530-536 |
Buy |
Stability of Clopidogrel in Three Extemporaneously Compounded Oral Liquid Preparations |
Yamreudeewong Weeranuj, Dolence Eric Kurt, Teixeira M Glaucia
|
Sep/Oct 2011 |
435-437 |
Buy |
Quality Control: Undecided About Buying an In-House Water Purification System? Pros, Cons, and Caveats That May Provide the Answers You Need |
Mixon William, Fox Samantha, Barnes Danny, Stuart William, Betlach Verne, Hall Richard M, Biller Jeremy, Kelly Russ, Janik Peter, Purcell Julian
|
Nov/Dec 2011 |
480-487 |
Buy |
Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags |
Kaiser Jeanette, Kramer Irene
|
Nov/Dec 2011 |
515-520 |
Buy |
Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety |
Johnson Kain, Sully Andrew, Anthenat Bruce
|
Jul/Aug 2014 |
270-276 |
Buy |
Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2 |
Vu Nicole, Lou Jessica R, Kupiec Thomas C
|
Jul/Aug 2014 |
305-310 |
Buy |
Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy |
Palma Elisabetta, Bufarini Celestino
|
Sep/Oct 2014 |
358-364 |
Buy |
Basics of Compounding: Tips and Hints, Part 5: Facilities and Equipment |
Allen Loyd V Jr
|
Sep/Oct 2014 |
401-404 |
Buy |
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition |
Bourget Philippe, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard
|
Sep/Oct 2014 |
427-431 |
Buy |
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists |
Mixon Bill, Nain John
|
May/Jun 2013 |
182-190 |
Buy |
Decontamination Technology: The Missing Element |
Rahe Hank
|
May/Jun 2013 |
193-199 |
Buy |
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations |
McElhiney Linda F
|
Jul/Aug 2013 |
307-311 |
Buy |
Good Enough for America |
Worthen Dennis B
|
Jan/Feb 2014 |
20-29 |
Buy |
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective |
Timko Robert J, Crooker Philip EM
|
Mar/Apr 2014 |
101-111 |
Buy |
Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding |
Vu Nicole, Nguyen Devin, Kupiec Thomas C
|
Mar/Apr 2014 |
123-130 |
Buy |
Quality Control Analytical Methods: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 1 |
Vu Nicole, Lou Jessica R, Kupiec Thomas
|
May/Jun 2014 |
213-221 |
Buy |
Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms |
Akers Michael J
|
Nov/Dec 2014 |
479-484 |
Buy |
Stability Assessment of Repackaged Bevacizumab for Intravitreal Administration |
Pereboom Marieke, Becker Matthijs L, Amenchar Mostapha, Verweij Sjoerd L, van der Hoeven Ruud TM, Mulder Inge J
|
Jan/Feb 2015 |
70-72 |
Buy |
Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions |
Amin Alexandre, Bourget Philippe, Vidal Fabrice, Cartier Francois, Beauvais Raphaelle, Do Nascimento Afonso Veronica
|
Jan/Feb 2015 |
73-77 |
Buy |
New England Compounding Center Indictment |
Cabaleiro Joe
|
Mar/Apr 2015 |
94-102 |
Buy |
Basics of Sterile Compounding: Barrier Isolator Technologist in Aseptic Processing |
Akers Michael J
|
Jul/Aug 2015 |
315-320 |
Buy |
Sterile Filtration |
Akers Michael J
|
Sep/Oct 2015 |
393-401 |
Buy |
Microbial Identification in Pharmaceutical Compounding |
Hyde Tiffany, Anstead James, Schade Lisa, Zellner James
|
Jan/Feb 2016 |
13-18 |
Buy |
Root Cause Analysis, Part 2: Sterile Compounding |
Cabaleiro Joe, Jackson Kathleen
|
Mar/Apr 2016 |
99-104 |
Buy |
Formulation and Stability of Solutions |
Akers Michael J
|
Mar/Apr 2016 |
137-141 |
Buy |
Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal) |
Garrigue Philippe, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
|
Mar/Apr 2016 |
148-154 |
Buy |
Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration |
Akers Michael J
|
May/Jun 2016 |
217-222 |
Buy |
Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Would Care Compounding Preparations |
Lupatini Nogueira Rodrigo José, Danopoulos Panagiota, Swikidisa Rosita, Alves Pinheiro Vanessa
|
Jul/Aug 2016 |
333-337 |
Buy |
PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives |
Allen Loyd V Jr
|
May/Jun 2017 |
180 |
Buy |
Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding |
Ligugnana Roberto
|
May/Jun 2017 |
182-190 |
Buy |
Microbiologic Testing for 503A Sterile-Compounding Pharmacies |
Mixon William, Roth Abby
|
May/Jun 2017 |
193-203 |
Buy |
Basics of Sterile Compounding: Manipulating Peptides and Proteins |
Akers Michael J
|
May/Jun 2017 |
223-228 |
Buy |
Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas |
Choo Winnie
|
Jul/Aug 2017 |
282-289 |
Buy |
Basics of Sterile Compounding: Particulate Matter |
Akers Michael J
|
Sep/Oct 2017 |
395-404 |
Buy |
Auditing Safety of Compounding and Reconstituting of Intravenous Medicines on Hospital Wards in Finland |
Suvikas-Peltonen Eeva, Palmgren Joni, Häggman Verner, Celikkayalar Ercan, Manninen Raija, Airaksinen Marja
|
Nov/Dec 2017 |
518-529 |
Buy |
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1 |
Williams LaVonn
|
Jul/Aug 2018 |
284-287 |
Buy |
Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating |
Martin Matt
|
Jul/Aug 2018 |
303-312 |
Buy |
Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding |
Martin Matt
|
Jan/Feb 2019 |
47-49 |
Buy |
Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding? |
Allen Loyd V Jr
|
Mar/Apr 2019 |
123-130 |
Buy |
Basics of Sterile Compounding: Vehicles Used in Sterile Compounding |
Allen Loyd V Jr
|
May/Jun 2019 |
221-228 |
Buy |
Certification of Powder-containment Hoods for Nonsterile Compounding |
Mulder Kyle, Dozzi Raphael
|
Sep/Oct 2018 |
369-384 |
Buy |
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations |
Ashe Krystina, Baskett Dustin
|
Sep/Oct 2018 |
387-398 |
Buy |
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 |
Martin Matt
|
Sep/Oct 2018 |
401-404 |
Buy |
Quality Assurance and Quality Control, Part 2 |
Akers Michael J
|
May/Jun 2015 |
215-221 |
Buy |
Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 1 |
Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
|
Sep/Oct 2019 |
387-391 |
Buy |
Stability of Furosemide 5 mg/mL in Polypropylene Syringes |
van der Schaar JAJ, Grouls R, Franssen EJF, Crul M
|
Sep/Oct 2019 |
414-417 |
Buy |
Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 2 |
Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
|
Nov/Dec 2019 |
467-471 |
Buy |
Basics: Excipients Used in Nonsterile Compounding, Part 3: Preservatives |
Allen Loyd V Jr
|
Nov/Dec 2019 |
472-477 |
Buy |
Primary Engineering Controls in Pharmaceutical Compounding, Part 2: Biosafety Cabinets |
Mulder Kyle
|
Jan/Feb 2020 |
7-12 |
Buy |
Evaluation of the Efficacy and Superiority of Different Vial Rubber Closure Disinfection Techniques |
Bjornstad Matthew, Kosinski Tracy, Burlage Robert
|
Sep/Oct 2020 |
434-438 |
Buy |
Establishing a Structured Pharmacy Training Program in Sterile Compounding |
Dirbas Muhannad, AbuSara Aseel K, Whiyabi Shatha, Harb Rema, Telfah Shorouq
|
Nov/Dec 2020 |
460-465 |
Buy |
Compounding Pearls -- Wound Care: Burn Healing, Part 2 |
Riepl Mike
|
Jul/Aug 2020 |
282-285 |
Buy |
Quality Control: Rapid Sterility Testing for Compounding Pharmacies |
Taylor Andrew
|
Jul/Aug 2020 |
299-303 |
Buy |
Incorporating Quality Assurance in Pharmaceutical Compounding-related Courses in the PharmD Curricula |
Hossain Mohammad Faisal, Levesque Dan, Frye John, Rashid Mamoon
|
Jul/Aug 2020 |
322-326 |
Buy |
Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations |
Allen Loyd V Jr
|
Jan/Feb 2021 |
31-38 |
Buy |
Descriptive Report of Individual State Responses to Personal Protective Equipment Shortages for Pharmacy Practice During the Covid-10 Pandemic |
Roberts Patricia A, Eberwein Samuel M, Youmans Danielle, Amerine Lindsey B
|
Mar/Apr 2021 |
109-113 |
Buy |
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation |
Allen Loyd V Jr
|
Mar/Apr 2021 |
131-139 |
Buy |
Stability of Fagron's Phytobase Cream Compounded with Various Hormones |
Wynn Tom, Taylor Sarah, Zander Clark
|
Mar/Apr 2021 |
156-162 |
Buy |
Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt |
Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
|
Mar/Apr 2021 |
169-175 |
Buy |